SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001610717-24-000347
Filing Date
2024-06-20
Accepted
2024-06-20 16:10:50
Documents
1
Period of Report
2024-06-17

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3963
  Complete submission text file 0001610717-24-000347.txt   5373
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Issuer) CIK: 0001628171 (see all company filings)

IRS No.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ERASCA, INC. 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121
Business Address
Wei Lin (Reporting) CIK: 0001872772 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39219 | Film No.: 241056324